Horsley Park (AU)
{name}
{subtitle}
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~9 mi. (Liverpool, Australia, +144 more cities)
facility
Liverpool Hospital ( Site 4006)
condition
Clear Cell Renal Cell Carcinoma
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~9 mi. (Liverpool, Australia, +199 more cities)
facility
Liverpool Hospital ( Site 0226)
condition
Hepatocellular Carcinoma
drug
pembrolizumab
drug type
immunotherapy
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~9 mi. (Liverpool, Australia, +127 more cities)
facility
Liverpool Hospital
biomarker
BRAF V600E
condition
Colorectal Carcinoma
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
city
~9 mi. (Liverpool, Australia, +92 more cities)
facility
Liverpool Hospital ( Site 0220)
condition
Bladder Urothelial Carcinoma
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer
city
~9 mi. (Blacktown, Australia, +151 more cities)
facility
GSK Investigational Site
condition
Non-Small Cell Lung Carcinoma
drug
niraparib, +1 more drug
drug type
immunotherapy, +1 more type
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
city
~9 mi. (Liverpool, Australia, +105 more cities)
facility
Liverpool Hospital ( Site 0055)
condition
Colorectal Adenocarcinoma
drug
bevacizumab, +1 more drug
drug type
targeted therapy
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~9 mi. (Blacktown, Australia, +201 more cities)
facility
Blacktown Hospital /ID# 234079
condition
Myelodysplastic Syndromes
drug
azacitidine, +1 more drug
drug type
chemotherapy
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
city
~9 mi. (Liverpool, Australia, +141 more cities)
facility
GSK Investigational Site
condition
Multiple Myeloma
drug
belantamab mafodotin
drug type
chemotherapy, +1 more type
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~9 mi. (Liverpool, Australia, +197 more cities)
facility
Liverpool Hospital /ID# 215415
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
condition
Acute Myeloid Leukemia
drug
azacitidine, +1 more drug
drug type
chemotherapy